An overview of the mechanisms and novel roles of Nrf2 in cardiovascular diseases

被引:30
|
作者
Jiang, Shuai [1 ,4 ]
Yang, Yang [2 ,3 ]
Li, Tian [2 ]
Ma, Zhiqiang [5 ]
Hu, Wei [2 ]
Deng, Chao [1 ]
Fan, Chongxi [5 ]
Lv, Jianjun [2 ]
Sun, Yang [6 ]
Yi, Wei [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, 127 Changle West Rd, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Dept Biomed Engn, Xian, Peoples R China
[3] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Thorac & Cardiovasc Surg, Nanjing, Jiangsu, Peoples R China
[4] Fourth Mil Med Univ, Dept Aerosp Med, Xian, Peoples R China
[5] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian, Peoples R China
[6] Fourth Mil Med Univ, Xijing Hosp, Dept Geriatr, Xian, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Nuclear factor erythroid 2-related factor 2; cardiovascular system; potential research directions; oxidative stress; NF-KAPPA-B; INDUCED ENDOTHELIAL DYSFUNCTION; ISCHEMIA-REPERFUSION INJURY; INDUCED OXIDATIVE STRESS; UP-REGULATION; HEART-FAILURE; DIABETIC CARDIOMYOPATHY; ATTENUATES INFLAMMATION; MYOCARDIAL-INFARCTION; SULFORAPHANE PROTECTS;
D O I
10.1080/14728222.2016.1250887
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Nuclear factor erythroid 2-related factor 2 (Nrf2) is a basic leucine zipper (bZIP) transcription factor of the cap'n'collar (CNC) family that is present in various organs. The cardiovascular system (CVS) is susceptible to a spectrum of diseases that are strongly associated with increased risks of mortality and morbidity, and studies have demonstrated that Nrf2 has a pivotal role in protection against cardiovascular diseases (CVDs).Areas covered: Nrf2 is a basic protective molecule that guards against CVD by attenuating oxidative stress, mitochondrial dysfunction, and inflammation. Initially, we briefly introduce the biological characteristics of Nrf2 and the newly discovered Neh7 domain. Next, we discuss the concrete roles of Nrf2 in the CVS and enumerate some related upstream molecules and downstream targets. Lastly, we expand our focus to the behaviors of Nrf2 in CVDs and discuss potential research directions.Expert opinion: Although certain studies have cast doubt on the positive actions of Nrf2 in the CVS, Nrf2 is a pivotal endogenous molecule for defense against CVD. The review compiled here may serve as a broad and comprehensive reference for the roles of Nrf2 in the CVS, with the aim of facilitating the design of new drugs and clinical therapies for CVDs.
引用
下载
收藏
页码:1413 / 1424
页数:12
相关论文
共 50 条
  • [31] The Role of Nrf2 in Cardiovascular Function and Disease
    Satta, Sandro
    Mahmoud, Ayman M.
    Wilkinson, Fiona L.
    Alexander, M. Yvonne
    White, Stephen J.
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2017, 2017
  • [32] Nrf2 in aging - Focus on the cardiovascular system
    Kloska, Damian
    Kopacz, Aleksandra
    Piechota-Polanczyk, Aleksandra
    Nowak, Witold N.
    Dulak, Jozef
    Jozkowicz, Alicia
    Grochot-Przeczek, Anna
    VASCULAR PHARMACOLOGY, 2019, 112 : 42 - 53
  • [33] Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implications
    Mayer, Clara
    Riera-Ponsati, Lluis
    Kauppinen, Sakari
    Klitgaard, Henrik
    Erler, Janine T.
    Hansen, Stine N.
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [34] The Role of Nrf2 in the Attenuation of Cardiovascular Disease
    Reuland, Danielle J.
    McCord, Joe M.
    Hamilton, Karyn L.
    EXERCISE AND SPORT SCIENCES REVIEWS, 2013, 41 (03): : 162 - 168
  • [35] The Nrf2 in the pathophysiology of the intestine: Molecular mechanisms and therapeutic implications for inflammatory bowel diseases
    Piotrowska, Marta
    Swierczynski, Mikolaj
    Fichna, Jakub
    Piechota-Polanczyk, Aleksandra
    PHARMACOLOGICAL RESEARCH, 2021, 163
  • [36] Activators of Nrf2 to Counteract Neurodegenerative Diseases
    Amoroso, Rosa
    Maccallini, Cristina
    Bellezza, Ilaria
    ANTIOXIDANTS, 2023, 12 (03)
  • [37] NRF2 as a Therapeutic Target in Neurodegenerative Diseases
    Brandes, Mikah S.
    Gray, Nora E.
    ASN NEURO, 2020, 12
  • [38] Nrf2 activator for the treatment of kidney diseases
    Yamawaki, Kengo
    Kanda, Hironori
    Shimazaki, Ryutaro
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2018, 360 : 30 - 37
  • [39] Nrf2 as a therapeutic target for rheumatic diseases
    Luisa Ferrandiz, Maria
    Nacher-Juan, Josep
    Jose Alcaraz, Maria
    BIOCHEMICAL PHARMACOLOGY, 2018, 152 : 338 - 346
  • [40] Role of Nrf2 in the pathogenesis of respiratory diseases
    Mizumura, Kenji
    Maruoka, Shuichiro
    Shimizu, Tetsuo
    Gon, Yasuhiro
    RESPIRATORY INVESTIGATION, 2020, 58 (01) : 28 - 35